Helix BioMedix, Inc. Announces the Launch of DermaVentures’ P.A.C. Perfect Product Line Through Joint Venture

BOTHELL, Wash.--(BUSINESS WIRE)--Helix BioMedix, Inc. (OTCBB:HXBM), a developer of bioactive peptides, today announced the launch of the P.A.C. PerfectTM (Peptide-powered Acne Control) product line through a joint venture with DermaVentures™, LLC, an alliance of some of the skincare industry’s leading innovators.
MORE ON THIS TOPIC